In our analysis, the MTHFD2 protein pattern was not associated with OS and RFS in patients with RCC, and its overexpression only suggested shorter overall survival in the group with pRCC, without statistical significance. This evidence concerns the gene MTHFD2 and renal cell carcinoma.